Development and validation of a novel multivariate risk score to guide biopsy decision for the diagnosis of clinically significant prostate cancer

OBJECTIVES: Selecting patients suspected of having prostate cancer (PCa) for a prostate biopsy remains a challenge. Prostate‐specific antigen (PSA)‐based testing is hampered by its low specificity that often leads to negative biopsy results or detection of clinically insignificant cancers, especiall...

Descripción completa

Detalles Bibliográficos
Autores principales: Klocker, Helmut, Golding, Bruno, Weber, Stephan, Steiner, Eberhard, Tennstedt, Pierre, Keller, Thomas, Schiess, Ralph, Gillessen, Silke, Horninger, Wolfgang, Steuber, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988838/
https://www.ncbi.nlm.nih.gov/pubmed/35474911
http://dx.doi.org/10.1002/bco2.8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988838/
https://www.ncbi.nlm.nih.gov/pubmed/35474911
http://dx.doi.org/10.1002/bco2.8

Ejemplares similares